论文信息 - Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial - 字舞流文

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial

R. Lipton | L. Severt | M. Butler | J. Ailani | K. Lu | M. Finnegan | J. Trugman | Kerry Knievel | Susan Hutchinson | Sung Yun Yu | Kerry L Knievel | S. Yu | Joel M. Trugman